Nanoparticle-Based Drug Delivery

Nanoparticle-based drug delivery research engineers tiny particles—typically between one and a few hundred nanometers—to carry therapeutic compounds through the body and release them preferentially at disease sites such as tumors. By carefully controlling a nanoparticle's size, shape, and surface chemistry, researchers can exploit biological phenomena like the enhanced permeability and retention effect, or attach targeting ligands that steer the carrier toward specific cell types, reducing the collateral damage that conventional chemotherapy inflicts on healthy tissue. Magnetic nanoparticles add a further layer of control, allowing an external field to guide accumulation or trigger localized release. Central open questions include how to make tumor targeting reliable enough in human patients to match the precision seen in laboratory models, and how to design particles that clear the body safely once their cargo is delivered.

Works

90,540

Total citations

2,880,745

Keywords

NanocarriersDrug DeliveryNanoparticlesCancer TherapySurface EngineeringMagnetic Nanoparticles